Reasons for non‐treatment of hepatitis C in veterans in care
- 17 January 2005
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 12 (1), 81-85
- https://doi.org/10.1111/j.1365-2893.2005.00547.x
Abstract
We prospectively studied 354 patients with hepatitis C virus (HCV) infection who were referred to a hepatology specialty clinic to find the reasons for non-treatment of HCV. The median age was 48 years (range 27-77 years), 98.5% were male and 71% were white. Seventy per cent of the patients were not treated. The most common reasons for non-treatment were non-adherence to follow-up visit (24%), normal liver enzymes (14%), concurrent medical problems (11%), alcohol and drug use (9%), psychiatric problems (7%), advanced liver disease (7%), referral for transplant evaluation (6.4%) and patient refusal, transfer of care to another facility and non-detectable HCV RNA levels (5% each). The reason was not recorded for 5% of the patients and was treatment deferred in 2.4% while waiting for pegylated interferon approval. Non-treatment was more likely in patients with less than 12 years of education and a history of incarceration. Patients who were lost to follow-up and refused treatment were more likely to have current alcohol and drug use and a history of incarceration.Keywords
This publication has 16 references indexed in Scilit:
- Testing, Referral, and Treatment Patterns for Hepatitis C Virus Coinfection in a Cohort of Veterans with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2003
- Prevalence and risk factors for hepatitis C virus infection at an Urban veterans administration medical centerHepatology, 2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- The Natural History of Hepatitis C Virus InfectionJAMA, 2000
- Prevalence of Hepatitis C Virus Seropositivity among Hospitalized US VeteransThe American Journal of the Medical Sciences, 2000
- Prevalence of Hepatitis C Virus Seropositivity among Hospitalized US VeteransThe American Journal of the Medical Sciences, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in JapanAnnals of Internal Medicine, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Correlates of Hepatitis C Virus Infections among Injection Drug UsersMedicine, 1995